Immunocontraception in male feral swine treated with a recombinant gonadotropin-releasing hormone vaccineUSDA National Wildlife Research Center - Staff Publications
Date of this Version6-1-2010
AbstractObjective: To determine if a recombinant gonadotropin-releasing hormone (GnRH) vaccine is a potential immunocontraceptive agent for juvenile male feral swine. Results: As expected, a single dose of GonaCon vaccine reduced testes mass, serum testosterone, and percent normal tubules, and restricted sperm development at each stage. These reductions in reproductive development were associated with elevated GnRH antibodies. The single injection of rGnRH was not as effective in reducing these reproductive parameters; however, the two-dose injection of rGnRH was as effective as the single injection of GonaCon.
Citation InformationTyler A. Campbell, Michelle R. Garcia, Lowell A. Miller, Martha A. Ramirez, et al.. "Immunocontraception in male feral swine treated with a recombinant gonadotropin-releasing hormone vaccine" (2010)
Available at: http://works.bepress.com/tyler_campbell/12/